📢 New review in J Headache Pain!
Revisiting the estrogen withdrawal hypothesis for menstrual migraine 🔍
Existing studies are limited by methodologic inconsistencies 🧐
More research is needed to understand the migraine-estrogen relationship 🧠
Read more: https://t.co/4IoYhr7OWE
📢 New review in the @TheLancetNeuro:
Migraine evolves throughout life, peaking in the late 30s & often remitting with older age 🧐
Yet, diagnosing & treating in older adults can be challenging 🔍
The biology of remission? Still a mystery 🧠
Read more: https://t.co/Hw015xCXYR
Thien Phu Do concludes the #ScientificSession 2 by presenting: Second messenger signaling bypasses blockade of the calcitonin gene-related peptide (CGRP) receptor to provoke migraine attacks in humans. #EHC2022
Each quarter @ahsheadache@HeadacheJournal recognizes exceptional trainees who publish in our Journal. Read about this quarter’s highlighted individuals in the free to read editorial by @BobkerMd:
https://t.co/zmp5e116MZ
#Headache continues to be a problem, even in a country with easily accessible services. It is insufficient merely to make headache services available: public education – in when, how and when not to use these services – is also needed if they are to reach all who would benefit.
One-quarter of individuals with #headache occurring once or more every week have never consulted a medical doctor. Many people, even those with the highest burden, are hesitant to make use of headache services: https://t.co/UPDjlhrmhJ
@ihs_official@ahsheadache@EHF_Official
A multicentre, multi-arm, phase 3b trial demonstrated that #eptinezumab provided significant #migraine preventive effects compared with placebo in adults with migraine and 2-4 previous preventive treatment failures: https://t.co/7VRk7MogMg
@TheLancetNeuro@MessoudAshina
Real-world data of #erenumab in 300 patients over 52 weeks! Among patients with chronic #migraine and previous failure of medications for migraine #prevention, erenumab was found to be effective and well-tolerated: https://t.co/l1b12Cq5bQ
@ihs_official@EHF_Official@ahsheadache
@BrainPrize lectures now at the @UCPH_health! The @lundbeckfonden awarded the @BrainPrize 2022 to Professors Silvia Arber, Ole Kiehn and Martyn Goulding for having revolutionized our understanding of the neuronal cell types and circuits underlying #movement.
Just now, #Jakobinerklubben awarded @drfa_CPH the Medal of Honor. The medal is awarded to younger Danes (<40 years) who have carried out particularly meritorious and promising research in biomedicine. Congratulations on this acknowledgement, @drfa_CPH! We are all proud of you!
Lunch break until 1:00 pm CET. We will open the second session with Dr. Jakob M. Hansen and "The Therapeutic Promise of Neuromodulation in #Migraine". Stay tuned! See you in ~30 min on live stream @ https://t.co/yob5XXL1je
@ihs_official@EHF_Official@ahsheadache@EANeurology